Advances in respiratory virus therapeutics - A meeting report from the 6th for isirv Antiviral Group conference

被引：118

作者：

Beigel, John H. ^{[1
]}

Nam, Hannah H. ^{[2
]}

Adams, Peter L. ^{[3
]}

Krafft, Amy ^{[1
]}

Ince, William L. ^{[4
]}

El-Kamary, Sutler S. ^{[4
]}

Sims, Amy C. ^{[5
]}

机构：

[1] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA

[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[3] US Dept HHS, BARDA, Off Assistant Secretary Preparedness & Response A, Washington, DC 20201 USA

[4] US FDA, Div Antiviral Prod, Off Antimicrobial Prod, Off New Drugs,Ctr Drug Evaluat & Res, Silver Spring, MD USA

[5] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA

来源：

ANTIVIRAL RESEARCH | 2019年 / 167卷

关键词：

Influenza; Respiratory syncytial virus; Coronavirus; Antiviral therapy; Host-directed therapeutics; HUMAN MONOCLONAL-ANTIBODY; MERS-COV INFECTION; SYNCYTIAL VIRUS; SYNDROME CORONAVIRUS; INFLUENZA-A; DOUBLE-BLIND; HIGH-RISK; NEURAMINIDASE INHIBITORS; UNCOMPLICATED INFLUENZA; VIRAL-INFECTIONS;

D O I：

10.1016/j.antiviral.2019.04.006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The International Society for Influenza and other Respiratory Virus Diseases held its 6th Antiviral Group (isirv-AVG) conference in Rockville, Maryland, November 13-15, 2018. The three-day program was focused on therapeutics towards seasonal and pandemic influenza, respiratory syncytial virus, coronaviruses including MERS-CoV and SARS-CoV, human rhinovirus, and other respiratory viruses. Updates were presented on several influenza antivirals including baloxavir, CC-42344, VIS410, immunoglobulin, immune plasma, MHAA4549A, pimodivir (JNJ-63623872), umifenovir, and HA minibinders; RSV antivirals including presatovir (GS-5806), ziresovir (AK0529), lumicitabine (ALS-008176), JNJ-53718678, JNJ-64417184, and EDP-938; broad spectrum antivirals such as favipiravir, VH244, remdesivir, and EIDD-1931/EIDD-2801; and host directed strategies including nitazoxanide, eritoran, and diltiazem. Other topics included considerations of novel endpoints such as ordinal scales and patient reported outcomes (PRO), and study design issues, and other regulatory considerations for antiviral drug development. The aim of this report is to provide a summary of the presentations given at this meeting.

引用

页码：45 / 67

页数：23

共 145 条

[51] Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin [J].

Fleishman, Sarel J. ;

Whitehead, Timothy A. ;

Ekiert, Damian C. ;

Dreyfus, Cyrille ;

Corn, Jacob E. ;

Strauch, Eva-Maria ;

Wilson, Ian A. ;

Baker, David .

SCIENCE, 2011, 332 (6031) :816-821

[52] Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection [J].

Fukao, Keita ;

Noshi, Takeshi ;

Yamamoto, Atsuko ;

Kitano, Mitsutaka ;

Ando, Yoshinori ;

Noda, Takahiro ;

Baba, Kaoru ;

Matsumoto, Kazumi ;

Higuchi, Naoko ;

Ikeda, Minoru ;

Shishido, Takao ;

Naito, Akira .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (03) :654-662

[53] Favipiravir (T-705), a novel viral RNA polymerase inhibitor [J].

Furuta, Yousuke ;

Gowen, Brian B. ;

Takahashi, Kazumi ;

Shiraki, Kimiyasu ;

Smee, Donald F. ;

Barnard, Dale L. .

ANTIVIRAL RESEARCH, 2013, 100 (02) :446-454

[54] A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation [J].

Gaggar, Amit ;

Jackson, Patricia L. ;

Noerager, Brett D. ;

O'Reilly, Philip J. ;

McQuaid, D. Brent ;

Rowe, Steven M. ;

Clancy, J. P. ;

Blalock, J. Edwin .

JOURNAL OF IMMUNOLOGY, 2008, 180 (08) :5662-5669

[55] Efficacy and Safety of Nitazoxanide in Addition to Standard of Care for the Treatment of Severe Acute Respiratory Illness [J].

Gamino-Arroyo, Ana E. ;

Lourdes Guerrero, M. ;

McCarthy, Sean ;

Ramirez-Venegas, Alejandra ;

Llamosas-Gallardo, Beatriz ;

Galindo-Fraga, Arturo ;

Moreno-Espinosa, Sarbelio ;

Roldan-Aragon, Yuri ;

Araujo-Melendez, Javier ;

Hunsberger, Sally ;

Ibarra-Gonzalez, Violeta ;

Martinez-Lopez, Julia ;

Garcia-Andrade, Luis A. ;

Kapushoc, Heather ;

Holley, H. Preston ;

Smolskis, Mary C. ;

Ruiz-Palacios, Guillermo M. ;

Beigel, John H. ;

Bautista, Nora ;

Nolasco-Reza, Angelica ;

Ortiz-Hernandez, Ana A. ;

Andrade-Platas, Diana ;

Estevez-Jimenez, Juliana ;

Roa-Martinez, Bricia ;

Cruz-Gaona, Itzel ;

Aguilar-Cruz, Diana ;

Gonzalez-Matus, Monica ;

Mendoza-Garces, Luis ;

Perea-Guzman, Norma ;

Sandoval-Gutierrez, Ana ;

Hernandez-Ramirez, Daniel ;

Gerardo Hernandez-Sanchez, Pedro ;

del Carmen Baez-Cruz, Juana ;

Davila-Cruz, Alejandra N. ;

Grue, Louis ;

Burge, Gregory ;

Cox, Roxanne ;

Holley, Preston, Jr. ;

Cristillo, Anthony ;

Nahed, Nasreen ;

Lopez, Wendolyne ;

Mascarenas-Ruiz, Jessica ;

Xchel Becerril-Ruiz, Eli ;

Quidgley, Peter ;

Arroyo-Figueroa, Hugo .

CLINICAL INFECTIOUS DISEASES, 2019, 69 (11) :1903-1911

[56] Pharmacokinetics of oseltamivir in breast milk and maternal plasma [J].

Greer, Laura G. ;

Leff, Richard D. ;

Rogers, Vanessa Laibl ;

Roberts, Scott W. ;

McCracken, George H., Jr. ;

Wendel, George D., Jr. ;

Sheffield, Jeanne S. .

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 (06) :524.e1-524.e4

[57] Assessing baloxavir susceptibility of influenza viruses circulating in the United States during the 2016/17 and 2017/18 seasons [J].

Gubareva, Larisa V. ;

Mishin, Vasiliy P. ;

Patel, Mira C. ;

Chesnokov, Anton ;

Nguyen, Ha T. ;

De La Cruz, Juan ;

Spencer, Sarah ;

Campbell, Angela P. ;

Sinner, Mallory ;

Reid, Heather ;

Garten, Rebecca ;

Katz, Jackie M. ;

Fry, Alicia M. ;

Barnes, John ;

Wentworth, David E. .

EUROSURVEILLANCE, 2019, 24 (03) :13-17

[58] Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2015-2016 [J].

Gubareva, Larisa V. ;

Besselaar, Terry G. ;

Daniels, Rod S. ;

Fry, Alicia ;

Gregory, Vicki ;

Huang, Weijuan ;

Hurt, Aeron C. ;

Jorquera, Patricia A. ;

Lackenby, Angie ;

Leang, Sook-Kwan ;

Lo, Janice ;

Pereyaslov, Dmitriy ;

Rebelo-de-Andrade, Helena ;

Siqueira, Marilda M. ;

Takashita, Emi ;

Odagiri, Takato ;

Wang, Dayan ;

Zhang, Wenqing ;

Meijer, Adam .

ANTIVIRAL RESEARCH, 2017, 146 :12-20

[59] Preclinical pharmacokinetics of MHAA4549A, a human monoclonal antibody to influenza A virus, and the prediction of its efficacious clinical dose for the treatment of patients hospitalized with influenza A [J].

Gupta, Priyanka ;

Kamath, Amrita V. ;

Park, Summer ;

Chiu, Henry ;

Lutman, Jeff ;

Maia, Mauricio ;

Tan, Man-Wah ;

Xu, Min ;

Swem, Lee ;

Deng, Rong .

MABS, 2016, 8 (05) :991-997

[60] Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial [J].

Haffizulla, Jason ;

Hartman, Aaron ;

Hoppers, Melanie ;

Resnick, Harvey ;

Samudrala, Steve ;

Ginocchio, Christine ;

Bardin, Matthew ;

Rossignol, Jean-Francois .

LANCET INFECTIOUS DISEASES, 2014, 14 (07) :609-618

← 1 2 3 4 5 6 7 8 9 10 →